| Primary |
| Pain |
37.9% |
| Arthritis |
12.1% |
| Rheumatoid Arthritis |
6.9% |
| Arthralgia |
5.2% |
| Inflammation |
5.2% |
| Hypertension |
3.4% |
| Musculoskeletal Pain |
3.4% |
| Osteoarthritis |
3.4% |
| Plantar Fasciitis |
3.4% |
| Abdominal Pain Upper |
1.7% |
| Antiinflammatory Therapy |
1.7% |
| Anxiety |
1.7% |
| Back Pain |
1.7% |
| Blood Pressure Increased |
1.7% |
| Bursitis |
1.7% |
| Chondrocalcinosis Pyrophosphate |
1.7% |
| Costochondritis |
1.7% |
| Erythema |
1.7% |
| Hormone Replacement Therapy |
1.7% |
| Hypersensitivity |
1.7% |
|
| Toxic Epidermal Necrolysis |
10.0% |
| Dyspnoea |
6.7% |
| Gastric Haemorrhage |
6.7% |
| Gastrointestinal Haemorrhage |
6.7% |
| Hypersensitivity |
6.7% |
| Rash |
6.7% |
| Vision Blurred |
6.7% |
| Vomiting |
6.7% |
| Weight Decreased |
6.7% |
| Abdominal Discomfort |
3.3% |
| Abdominal Distension |
3.3% |
| Abdominal Rigidity |
3.3% |
| Angioedema |
3.3% |
| Cerebrovascular Accident |
3.3% |
| Crohn's Disease |
3.3% |
| Drug Hypersensitivity |
3.3% |
| Drug Ineffective |
3.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Gallbladder Enlargement |
3.3% |
| Gastric Ulcer |
3.3% |
|
| Secondary |
| Headache |
28.2% |
| Bone Disorder |
13.7% |
| Respiratory Disorder |
13.7% |
| Product Used For Unknown Indication |
13.5% |
| Drug Use For Unknown Indication |
5.6% |
| Rheumatoid Arthritis |
3.6% |
| Osteoarthritis |
3.1% |
| Bone Pain |
2.9% |
| Pain |
2.7% |
| Back Pain |
2.5% |
| Hypertension |
2.5% |
| Arthritis |
2.0% |
| Juvenile Arthritis |
1.1% |
| Musculoskeletal Pain |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Desmoid Tumour |
0.7% |
| Ill-defined Disorder |
0.7% |
| Inflammation |
0.7% |
| Multiple Sclerosis |
0.5% |
| Progressive Multiple Sclerosis |
0.5% |
|
| Drug Hypersensitivity |
8.9% |
| Toxicity To Various Agents |
8.9% |
| Atrial Fibrillation |
7.1% |
| Paraesthesia Oral |
7.1% |
| Upper Gastrointestinal Haemorrhage |
7.1% |
| Vomiting |
7.1% |
| Crohn's Disease |
5.4% |
| Intestinal Diaphragm Disease |
5.4% |
| Rash |
5.4% |
| Constipation |
3.6% |
| Gastrointestinal Haemorrhage |
3.6% |
| Incorrect Drug Administration Rate |
3.6% |
| Intentional Drug Misuse |
3.6% |
| Pain |
3.6% |
| Poisoning |
3.6% |
| Pyrexia |
3.6% |
| Renal Impairment |
3.6% |
| Ulcer |
3.6% |
| Weight Decreased |
3.6% |
| Anaemia |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.6% |
| Rheumatoid Arthritis |
19.2% |
| Drug Use For Unknown Indication |
9.5% |
| Pain |
6.1% |
| Hypertension |
5.2% |
| Depression |
4.5% |
| Hormone Replacement Therapy |
4.5% |
| Hepatitis C |
4.0% |
| Anxiety |
3.1% |
| Osteoporosis |
2.3% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Arthritis |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Vitamin Supplementation |
1.8% |
| Psoriatic Arthropathy |
1.7% |
| Diabetes Mellitus |
1.6% |
| Sleep Disorder |
1.5% |
| Arthralgia |
1.4% |
| Insomnia |
1.4% |
| Back Pain |
1.4% |
|
| Weight Increased |
17.8% |
| Injection Site Pain |
6.8% |
| Myocardial Infarction |
6.4% |
| Vomiting |
6.4% |
| Nausea |
5.5% |
| Pain In Extremity |
5.5% |
| Weight Decreased |
5.0% |
| Urinary Tract Infection |
4.6% |
| Rash |
4.1% |
| Drug Ineffective |
3.7% |
| Pneumonia |
3.7% |
| Self-injurious Ideation |
3.7% |
| Stress |
3.7% |
| Uterine Leiomyoma |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Oedema Peripheral |
3.2% |
| Transient Ischaemic Attack |
3.2% |
| Visual Impairment |
3.2% |
| Wound Infection Pseudomonas |
3.2% |
| Wrong Technique In Drug Usage Process |
3.2% |
|
| Interacting |
| Ill-defined Disorder |
33.3% |
| Knee Arthroplasty |
33.3% |
| Thrombosis Prophylaxis |
33.3% |
|
| Dysarthria |
50.0% |
| Gastrointestinal Haemorrhage |
50.0% |
|
